About GBT
GBT is a company based in San Francisco (United States) founded in 2011 was acquired by Pfizer in August 2022.. GBT has raised $177.4 million across 4 funding rounds from investors including Pfizer, RA Capital and Perceptive Advisors. The company has 457 employees as of December 31, 2021. GBT operates in a competitive market with competitors including Editas Medicine, LogicBio, Kedrion, Modus Therapeutics and Cyclerion, among others.
- Headquarter San Francisco, United States
- Employees 457 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Global Blood Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of GBT
GBT has successfully raised a total of $177.4M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $48 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $48.0M
-
First Round
First Round
(13 Jun 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Series B - GBT | Valuation |
investors |
|
| Jan, 2015 | Amount | Series B - GBT | Valuation | Perceptive Advisors , Wellington |
|
| Jun, 2012 | Amount | Series A - GBT | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GBT
GBT has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, RA Capital and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GBT
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GBT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gbt Comparisons
Competitors of GBT
GBT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Editas Medicine, LogicBio, Kedrion, Modus Therapeutics and Cyclerion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed using CRISPR technology.
|
|
| domain | founded_year | HQ Location |
Viral vectors are developed for genetic and infectious disease treatments.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
|
|
| domain | founded_year | HQ Location |
Polysaccharide-based drug for Sickle Cell Disease treatment is developed.
|
|
| domain | founded_year | HQ Location |
Therapies for sickle cell disease and diabetic nephropathy are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gbt
Frequently Asked Questions about GBT
When was GBT founded?
GBT was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is GBT located?
GBT is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is GBT a funded company?
GBT is a funded company, having raised a total of $177.4M across 4 funding rounds to date. The company's 1st funding round was a Series A of $40.7M, raised on Jun 13, 2012.
How many employees does GBT have?
As of Dec 31, 2021, the latest employee count at GBT is 457.
What does GBT do?
GBT was founded in 2011 and is based in San Francisco, United States. Operations are centered on biotechnology, with small molecules developed specifically for sickle cell disease. The lead candidate, voxelotor (GBT440), is under investigation in Phase 3 clinical trials for this condition. Hemoglobin S polymerization is inhibited by the candidate through modulation of hemoglobins oxygen affinity.
Who are the top competitors of GBT?
GBT's top competitors include Editas Medicine, Kedrion and Emmaus Medical.
Who are GBT's investors?
GBT has 6 investors. Key investors include Pfizer, RA Capital, Perceptive Advisors, Wellington, and Deerfield.